Titus B. Ball - Mar 19, 2024 Form 3 Insider Report for BeiGene, Ltd. (BGNE)

Role
Principal Accounting Officer
Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
BGNE
Transactions as of
Mar 19, 2024
Transactions value $
$0
Form type
3
Date filed
3/26/2024, 05:26 PM
Next filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BGNE Ordinary Shares 23.5K Mar 19, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BGNE Share Option (Right to Buy) Mar 19, 2024 Ordinary Shares 14.7K $15.97 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying unvested restricted share units.
F2 These securities vest over a four-year period as follows: 25% on August 31, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney